Invention Grant
- Patent Title: Tolerogenic dendritic cells for treating myocardial infarction and manufacturing method thereof
-
Application No.: US14508842Application Date: 2014-10-07
-
Publication No.: US09833473B2Publication Date: 2017-12-05
- Inventor: Ki-Yuk Chang , Eun-Ho Choo , Hyo-Eun Park , Eun-Hye Park , Dae-Seog Lim , Jun-Ho Lee
- Applicant: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Applicant Address: KR Seoul
- Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Current Assignee: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: JHK Law
- Agent Joseph Hyosuk Kim
- Main IPC: A61K35/15
- IPC: A61K35/15 ; C12N5/0784 ; A61K35/12

Abstract:
Provided are the tolerogenic dendritic cells for treating a myocardial infarction and a method for preparing the same, and more particularly, the tolerogenic dendritic cells for treating a myocardial infarction, which can treat cardiac insufficiency that occurs by excessive remodeling of left ventricle in the heart muscle recovery process after an acute myocardial infarction, and a method for preparing the tolergenic dendritic cells. According to the present invention, the inflammatory reaction and the excessive remodeling of left ventricle in the heart muscle recovery process after a myocardial infarction can be inhibited, and thus, the incidence rate of cardiac insufficiency can be significantly reduced, thereby being effectively used for treating a myocardial infarction.
Public/Granted literature
- US20160095882A1 TOLEROGENIC DENDRITIC CELLS FOR TREATING MYOCARDIAL INFARCTION AND MANUFACTURING METHOD THEREOF Public/Granted day:2016-04-07
Information query
IPC分类: